Bedi Gurinder S, Roy Shuvendu P, Sharma Vishwadeep, Bhagat Seema V, Sanghavi Arti P, Muchhala Snehal S, Katare Sagar, Kotak Bhavesh P, Banerjee Ritwik
Orthopaedics, Fortis Healthcare, New Delhi, IND.
Medical Affairs, Dr. Reddy's Laboratories Ltd, Hyderabad, IND.
Cureus. 2024 May 8;16(5):e59935. doi: 10.7759/cureus.59935. eCollection 2024 May.
The routine use of multimodal analgesic modality results in lower pain scores with minimum side effects and opioid utilization.
A prospective, cross-sectional, observational study was conducted among orthopedicians practicing across India to assess the professional opinions on using analgesics to manage orthopedic pain effectively.
A total of 530 orthopedicians participated in this survey. Over 50% of the participants responded that tramadol with or without paracetamol was the choice of therapy for acute pain. Nearly 50% of the participants mentioned that multimodal interventions can sometimes help to manage pain. A total of 55.6% of participants mentioned that using Non-steroidal anti-inflammatory drugs was the most common in their clinical practice, while 25.7% of participants mentioned that they used tramadol more commonly in their clinical practice. As per clinical efficacy ranking, the combination of tramadol plus paracetamol (44.3%) was ranked first among analgesic combinations, followed by aceclofenac plus paracetamol (40.0%). The severity of pain (62.6%) followed by age (60.6%) and duration of therapy (52.6%) were the most common factors that should be considered while prescribing tramadol plus paracetamol combination. Gastrointestinal and renal are reported as the most common safety concerns encountered with analgesics.
The combination of tramadol and paracetamol was identified as the most preferred choice of analgesics for prolonged orthopedic pain management.
常规使用多模式镇痛方法可降低疼痛评分,副作用和阿片类药物使用量最小。
对印度各地执业的骨科医生进行了一项前瞻性、横断面观察性研究,以评估他们对有效使用镇痛药治疗骨科疼痛的专业意见。
共有530名骨科医生参与了此次调查。超过50%的参与者表示,曲马多加或不加对乙酰氨基酚是急性疼痛的治疗选择。近50%的参与者提到多模式干预有时有助于控制疼痛。共有55.6%的参与者提到在临床实践中使用非甾体抗炎药最为常见,而25.7%的参与者提到他们在临床实践中更常使用曲马多。根据临床疗效排名,曲马多加对乙酰氨基酚组合(44.3%)在镇痛组合中排名第一,其次是醋氯芬酸加对乙酰氨基酚(40.0%)。疼痛严重程度(62.6%)、年龄(60.6%)和治疗持续时间(52.6%)是开具曲马多加对乙酰氨基酚组合时最常考虑的因素。胃肠道和肾脏问题被报告为镇痛药最常见的安全问题。
曲马多和对乙酰氨基酚的组合被确定为长期骨科疼痛管理中最优选的镇痛药。